Trial intelligence / Profile preview

Pharmacokinetics of Relinqing granule and interaction with ciprofloxacin in healthy volunteers

ChiCTR-OPh-16010029Phase 4Recruiting

Sponsor
Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine
Start
Nov 2016
Modality
Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4 trial of Relinqing granules and ciprofloxacin in Urinary System Diseases ((none)) (5 arms), sponsored by Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine. Primary endpoints: protocatechuic acid in plasma, gallic acid in plasma and 3 more. Started Nov 2016; status: recruiting.

02

Drugs

Relinqing granulesciprofloxacin
03

Conditions

Urinary System Diseases ((none))

Beyond the preview

Go deeper on ChiCTR-OPh-16010029.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-OPh-16010029.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call